NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $279,000 | +17.2% | 20,657 | +56.1% | 0.03% | +6.2% |
| Q3 2021 | $238,000 | -65.5% | 13,231 | -67.1% | 0.03% | -65.2% |
| Q2 2021 | $689,000 | -14.9% | 40,156 | -0.9% | 0.09% | -18.6% |
| Q1 2021 | $810,000 | +27.8% | 40,506 | +8.6% | 0.11% | +18.9% |
| Q4 2020 | $634,000 | +3.1% | 37,306 | +0.7% | 0.10% | -6.9% |
| Q3 2020 | $615,000 | -26.7% | 37,056 | +2.3% | 0.10% | -31.5% |
| Q2 2020 | $839,000 | +57.7% | 36,231 | +21.7% | 0.15% | +33.0% |
| Q1 2020 | $532,000 | +25.8% | 29,781 | +51.9% | 0.11% | +62.3% |
| Q4 2019 | $423,000 | – | 19,600 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |